According to a national survey of 800 primary care physicians conducted by Pri-Med Institute, Boston, almost three-quarters of physicians who participated said that commercial support of CME by pharmaceutical companies is a good thing. Just 8 percent said they were less likely to attend a CME program that is underwritten by pharma funds, and only 10 percent viewed industry support as “negative.” Regardless of their feelings, an overwhelming 86 percent said whether a program is supported by ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Physicians Support Commercial Support, you'll get exclusive access to a large archive of premium content.

Already registered? here.